Xenovaccination of patients with skin melanoma: phase I/II clinical trial

被引：0
|
作者：
Moiseyenko, Vladimir [1 ]
Baldueva, I. [1 ]
Danilov, A. [1 ]
Danilov, A. [1 ]
机构：
[1] Russian Biotechnol, Moscow, Russia
来源：
TUMOR BIOLOGY | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [1] Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma
    Camacho, Luis H.
    Antonia, Scott
    Sosman, Jeffrey
    Kirkwood, John M.
    Gajewski, Thomas F.
    Redman, Bruce
    Pavlov, Dmitri
    Bulanhagui, Cecile
    Bozon, Viviana A.
    Gomez-Navarro, Jesus
    Ribas, Antoni
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1075 - 1081
  • [2] Immunogene therapy of human melanoma - Phase I/II clinical trial
    Mackiewicz, A
    Kapcinska, M
    Wiznerowicz, M
    Malicki, J
    Nawrocki, S
    Nowak, J
    Murawa, P
    Sibilska, E
    Kowalczyk, D
    Lange, A
    Hawley, RC
    Rose-John, S
    GENE THERAPY OF CANCER, 1998, 451 : 557 - 560
  • [3] Phase I/II clinical trial of immunotherapy by intratumoral administration of dendritic cells for patients with melanoma
    Saito, Masataka
    Fujita, Tomonobu
    Tanikawa, Akiko
    Ishida, Akaru
    Sakurai, Toshiharu
    Handa, Makoto
    Amagai, Masayuki
    Kawakami, Yutaka
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 328 - 328
  • [4] A phase I/II gene therapy trial in metastatic melanoma patients
    Adamina, Michel
    Weber, Walter P.
    Rosenthal, Rachel
    Schumacher, Reto
    Zajac, Paul
    Marti, Walter R.
    Huegli, Rolf
    Oertli, Daniel
    Spagnoli, Giulio
    Heberer, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (03) : S83 - S83
  • [5] Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients
    King, DM
    Albertini, MR
    Schalch, H
    Hank, JA
    Gan, J
    Surfus, J
    Mahvi, D
    Schiller, JH
    Warner, T
    Kim, K
    Eickhoff, J
    Kendra, K
    Reisfeld, R
    Gillies, SD
    Sondel, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) : 4463 - 4473
  • [6] Immuno-gene therapy of human melanoma phase I/II clinical trial
    Mackiewicz, A
    RoseJohn, S
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 34 - 34
  • [7] Phase II trial of karenitecin in patients with malignant melanoma: Clinical and translational study
    Daud, A
    Valkov, N
    Centeno, B
    Derderian, J
    Sullivan, P
    Munster, P
    Urbas, P
    DeConti, RC
    Berghorn, E
    Liu, ZM
    Hausheer, F
    Sullivan, D
    CLINICAL CANCER RESEARCH, 2005, 11 (08) : 3009 - 3016
  • [8] A phase I/II trial of the combination of bevacizumab, oxaliplatin, and sorafenib in patients with metastatic melanoma
    McClay, E. F.
    Bessudo, A.
    Frakes, L.
    Eisenberg, S.
    Just, R.
    Banerjee, P.
    Sinclair, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Outpatient combination chemoimmunotherapy for patients with metastatic melanoma - Results of a phase I/II trial
    Kashani-Sabet, M
    Sagebiel, RW
    Collins, HE
    Glassberg, AB
    Allen, RE
    Leong, SPL
    Small, EJ
    CANCER, 1999, 86 (10) : 2160 - 2165
  • [10] Preliminary results of a phase I/II clinical trial using in situ photoimmunotherapy combined with imiquimod for metastatic melanoma patients
    Li, Xiaosong
    Naylor, Mark F.
    Nordquist, Robert E.
    Teague, T. Kent
    Howard, C. Anthony
    Murray, Cynthia
    Chen, Wei R.
    BIOPHOTONICS AND IMMUNE RESPONSES V, 2010, 7565
12345